<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="165515">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00943189</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-08-4934-LG-CTIL</org_study_id>
    <nct_id>NCT00943189</nct_id>
  </id_info>
  <brief_title>Fetal Anomalies Scan at the Time of Nuchal Translucency Study</brief_title>
  <official_title>Fetal Anomalies Scan at the Time of Nuchal Translucency Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is
      conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal
      and transabdominal techniques. The patients will receive only the NT information. Only in
      cases of detection of severe fetal anomalies the patient will get the information of the
      examination and counseling according to the findings. All patients will be asked to provide
      information of the 15 weeks early comprehensive ultrasound examination. The NT examination
      will be compared to the 15 weeks ultrasound. All patients will be asked to give information
      after delivery of the baby's health condition.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Fetal Anomalies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All pregnant women at 12-14 weeks of gestation that are coming for nuchal translucency
        examination and willing to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant women at 12-14 weeks

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Liat Gindes, MD</last_name>
    <email>gindesl@smile.net.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liat Gindes, MD</last_name>
      <email>gindesl@smile.net.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <lastchanged_date>November 19, 2009</lastchanged_date>
  <firstreceived_date>July 21, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Liat Gindes</name_title>
    <organization>Sheba Medical Center</organization>
  </responsible_party>
  <keyword>Fetal anomalies scan at the time of NT study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
